Financials
- Market Capitalization 586.53 M
- Employee 353
- Founded 2012
- CEO David Moatazedi
- Website www.evolus.com
- Headquarter Delaware, United States
- FIGI BBG005CX4HK8
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2774 | AQST Aquestive Therapeutics, Inc. - Common Stock | 5.02 USD | -2.71% | +7.04% | +39.44% | +33.87% | 630.07 M USD | ||
| 2784 | TLRY Tilray Brands, Inc. - Common Stock | 4.59 USD | +0.44% | -3.97% | +16.20% | +258.59% | 625.17 M USD | ||
| 2945 | KMDA Kamada Ltd. - Ordinary Shares | 8.29 USD | +0.36% | -0.36% | +17.42% | +18.26% | 478.22 M USD | ||
| 3001 | BIOA BioAge Labs, Inc. - Common Stock | 9.65 USD | -4.27% | +0.84% | -56.82% | +26.97% | 442.91 M USD |
Frequently asked questions about Evolus, Inc. Common Stock
What is the Evolus, Inc. Common Stock stock price today?
The current price of Evolus, Inc. Common Stock (EOLS) is 8.88. Over the past 24 hours, the stock has changed by 0.00%. Follow the EOLS chart for real-time price dynamics.
What is the stock ticker of Evolus, Inc. Common Stock?
Evolus, Inc. Common Stock trades under the ticker EOLS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Evolus, Inc. Common Stock stock going up?
EOLS has changed by +5.84% over the last week, +48.74% over the last month, and +17.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Evolus, Inc. Common Stock?
Evolus, Inc. Common Stock currently has a market capitalization of 586.53 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Evolus, Inc. Common Stock earnings last quarter?
Last quarter, Evolus, Inc. Common Stock reported earnings of -0.12 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Evolus, Inc. Common Stock revenue for the last quarter?
Evolus, Inc. Common Stock reported quarterly revenue of 84.08 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Evolus, Inc. Common Stock net income for the last quarter?
Evolus, Inc. Common Stock reported net income of -8.05 M for the last quarter. The previous quarter showed -10.67 M, which means net income changed by +24.56%.
How many employees does Evolus, Inc. Common Stock have?
As of the latest available data, Evolus, Inc. Common Stock has 353 employees. Workforce size can provide additional context about the company's scale and operations.
What is Evolus, Inc. Common Stock EBITDA?
Evolus, Inc. Common Stock EBITDA is 24.7 M, and its EBITDA margin is 29.37%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Evolus, Inc. Common Stock stock?
You can buy Evolus, Inc. Common Stock (EOLS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Evolus, Inc. Common Stock stock?
Investing in Evolus, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the EOLS chart and related analysis on metatrader.com as part of your research.